Warning: implode(): Invalid arguments passed in /www/htdocs/w00d8752/html/includes/inc_partner.php on line 446

Institution statistics - INNOVATION

KAROLINSKA INSTITUTE - Sweden 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 INNOVATION):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 40
As coordinator: 11
As participant: 23
Sole participant: 6
Coordinator / Participant Ratio: 0.48*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 3.914.345 546.589 2
2010 3.782.107 399.600 1.681.547 5 1
2008 2.946.420 10.921.350 1.065.878 1 1
2007 0 6.092.772 739.145 3
2006 297.300 10.821.480 1.235.394 2 5
2005 1.879.800 0 268.543 1
2004 931.749 12.174.994 759.650 3 3
2003 0 1.604.661 267.444 1
2002 3.572.690 4.452.941 1.361.564 2 3
2001 0 5.932.049 799.400 3
2000 1.528.868 2.399.729 895.834 3 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE121
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE100
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE78
UNIVERSITY COLLEGE LONDON77
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD68
UNIVERSITY OF HELSINKI58
MEDICAL RESEARCH COUNCIL57
KING'S COLLEGE LONDON52
INSTITUT PASTEUR47
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE45
UPPSALA UNIVERSITET43
EUROPEAN MOLECULAR BIOLOGY LABORATORY41
STICHTING KATHOLIEKE UNIVERSITEIT38
ISTITUTO SUPERIORE DI SANITA37
KATHOLIEKE UNIVERSITEIT LEUVEN37
UNIVERSITY OF COPENHAGEN37
CHARITE UNIVERSITAETSMEDIZIN BERLIN36
COMMISSARIAT A L'ENERGIE ATOMIQUE36
LUNDS UNIVERSITET35
LEIDEN UNIVERSITY MEDICAL CENTER34
THE UNIVERSITY OF EDINBURGH34
UNIVERSITAET ZUERICH31
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT30
WEIZMANN INSTITUTE OF SCIENCE30
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS28
THE UNIVERSITY OF MANCHESTER28
UNIVERSITY OF OSLO28
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM27
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN27
UNIVERSITEIT UTRECHT27
CONSIGLIO NAZIONALE DELLE RICERCHE26
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV26
UNIVERSITA DEGLI STUDI DI MILANO25
UNIVERSITEIT MAASTRICHT25
UNIVERSITY OF GLASGOW25
UNIVERSITY OF LEEDS25
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS24
UNIVERSITE DE GENEVE24
KUNGLIGA TEKNISKA HOEGSKOLAN23
UNIVERSITY OF BIRMINGHAM23
DEUTSCHES KREBSFORSCHUNGSZENTRUM22
UNIVERSITAETSKLINIKUM HEIDELBERG22
UNIVERSITEIT GENT22
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS21
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS21
UNIVERSITY OF BERGEN21
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE20
UNIVERSITY OF TURKU20
THE HEBREW UNIVERSITY OF JERUSALEM19
UNIVERSITY OF NEWCASTLE UPON TYNE19
EBERHARD KARLS UNIVERSITAET TUEBINGEN18
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR18
GENOME RESEARCH18
HEINRICHHEINEUNIVERSITAET DUESSELDORF18
RUPRECHT KARLS UNIVERSITAET HEIDELBERG18
UNIVERSITE LIBRE DE BRUXELLES18
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE17
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V17
GSFRESEARCH CENTER FOR ENVIRONMENT AND HEALTH17
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE17
UNIVERSIDAD AUTONOMA DE MADRID17
UNIVERSITA DEGLI STUDI DI TORINO17
UNIVERSITY OF AARHUS17
UNIVERSITY OF WALES CARDIFF17
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER16
REGION HOVEDSTADEN16
STOCKHOLMS UNIVERSITET16
TERVEYDEN JA HYVINVOINNIN LAITOS16
UNIVERSITY OF LEICESTER16
UNIVERSITY OF SOUTHAMPTON16
UNIVERSITY OF TAMPERE16
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH15
INSTITUT GUSTAVE ROUSSY15
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT15
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO15
TECHNISCHE UNIVERSITAET MUENCHEN15
UMEA UNIVERSITET15
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA15
UNIVERSITAIR MEDISCH CENTRUM UTRECHT15
VTT TECHNICAL RESEARCH CENTRE OF FINLAND15
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM14
ACADEMISCH ZIEKENHUIS GRONINGEN14
DANISH CANCER SOCIETY14
GOETEBORGS UNIVERSITET14
HEALTH PROTECTION AGENCY14
MEDIZINISCHE UNIVERSITAET WIEN14
NORWEGIAN INSTITUTE OF PUBLIC HEALTH14
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON14
TECHNISCHE UNIVERSITAET DRESDEN14
TEL AVIV UNIVERSITY14
THE UNIVERSITY OF LIVERPOOL14
THE UNIVERSITY OF MILANO14
UNIVERSITA DEGLI STUDI DI PADOVA14
UNIVERSITAET BASEL14
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS14
UNIVERSITAT AUTONOMA DE BARCELONA14
UNIVERSITAT DE BARCELONA14
UNIVERSITE CATHOLIQUE DE LOUVAIN14
UNIVERSITY OF BOLOGNA14
UNIVERSITY OF EDINBURGH14
Constancy:

Total number of partners:8710

Partner loyalty:
Frequent Partner: (> 2 projects): 5353
Rare Partner: 3357

Frequent / Rare Partner Ratio: 1.59

Diversity:

Subjects:
Subject:No:
HEALTH362
MEDICINE362
LIFE SCIENCES330
SCIENTIFIC RESEARCH309
MEDICINE, HEALTH308
BIOTECHNOLOGY164
SOCIAL ASPECTS162
TRAINING112
EDUCATION112
COORDINATION107
COOPERATION107
COORDINATION, COOPERATION94
EDUCATION, TRAINING92
SAFETY66
ENVIRONMENTAL PROTECTION59
REGIONAL DEVELOPMENT58
MEDIA56
INFORMATION56
INFORMATION, MEDIA53
EVALUATION53
ECONOMIC ASPECTS48
MEDICINE AND HEALTH42
MEDICAL BIOTECHNOLOGY42
POLICIES42
TECHNOLOGY TRANSFER40
INNOVATION40
INNOVATION, TECHNOLOGY TRANSFER32
FOOD31
INFORMATION SYSTEMS22
WASTE MANAGEMENT22
INFORMATION PROCESSING, INFORMATION SYSTEMS22
INFORMATION PROCESSING22
AGRICULTURE19
NUCLEAR FISSION18
INDUSTRIAL MANUFACTURE18
HEALTHCARE DELIVERY/SERVICES16
TELECOMMUNICATIONS16
MICROELECTRONICS15
ELECTRONICS15
ELECTRONICS, MICROELECTRONICS13
REGULATIONS13
RADIATION PROTECTION13
LEGISLATION13
LEGISLATION, REGULATIONS12
EDUCATION AND TRAINING12
MATERIALS TECHNOLOGY11
EMPLOYMENT ISSUES11
FISHERIES10
FORECASTING10
RESOURCES OF THE SEA10
MEASUREMENT METHODS10
NUCLEAR FUSION9
RESOURCES OF THE SEA, FISHERIES9
INNOVATION AND TECHNOLOGY TRANSFER8
MATHEMATICS8
STANDARDS8
ENERGY STORAGE7
TRANSPORT7
AEROSPACE TECHNOLOGY7
OTHER ENERGY TOPICS7
ENERGY TRANSPORT7
RADIOACTIVE WASTE7
FOSSIL FUELS6
STATISTICS6
OTHER TECHNOLOGY6
NETWORK TECHNOLOGIES6
EARTH SCIENCES6
REFERENCE MATERIALS6
ENERGY SAVING6
ENERGY STORAGE, ENERGY TRANSPORT6
METEOROLOGY6
CONSTRUCTION TECHNOLOGY6
RENEWABLE SOURCES OF ENERGY6
INFORMATION AND COMMUNICATION TECHNOLOGY APPLICATIONS4
AGRICULTURAL BIOTECHNOLOGY4
NANOTECHNOLOGY AND NANOSCIENCES4
VETERINARY AND ANIMAL SCIENCES2
BUSINESS ASPECTS1
RESEARCH ETHICS1
SECURITY1
Diversity index:0.15
Categories:
Category:No:
BIOLOGICAL SCIENCES473
RTD HORIZONTAL TOPICS353
SOCIAL AND ECONOMIC CONCERNS226
PROTECTING MAN AND HIS ENVIRON98
INDUSTRY AND TECHNOLOGY52
AGRICULTURE AND MARINE RESOURC35
ENERGY19
MEASUREMENTS AND STANDARDS12
PHYSICAL AND EXACT SCIENCES8

Project overview:

Start dateProjectacronymrolefundingpartners
2011-05-01Human Brain Project HBPparticipant1.414.38813
2011-02-01Enhancing Human Resources and Use of Appropriate Training for Maternal and Perinatal Survival In Sub-Saharan Africa ETATMBAparticipant2.499.9576
2010-11-01Expanded Quality management Using Information Power for Maternal and Newborn Health in Africa EQUIPcoordinator2.998.4065
2010-11-01Molecular mechanisms of pediatric immunodeficiency syndromes affecting natural killer cell cytotoxicity NK in HLHcoordinator181.6691
2010-09-01Investigation of influenza immune responses and vaccine efficacy correlates by global expression profiling and immunological analyses in the ferret model of influenza FERFLU EXPRESScoordinator239.6931
2010-07-01Identification of New Genetic Determinants of Plasma Fibrinogen Concentration INDEFICcoordinator181.6691
2010-07-01Immunomodulatory Effects of Exercise in Type 1 Diabetes IMMEEDIAparticipant399.6005
2010-07-01Developmental Transcription Factors in Dopamine Neuron Maintenance Dopamine Neuron Codecoordinator180.6691
2008-11-01The antiretroviral roll out for HIV in India - strengthening capacity to promote adherence and patient follow-up in the context HIVINDcoordinator2.946.4206
2008-09-01Nanoparticles for therapy and diagnosis of Alzheimer disease NADparticipant10.921.35019
2007-02-01From gene regulatory networks to drug prediction NET2DRUGparticipant2.981.0009
2007-01-01Development of optimised recombinant idiotypic vaccines for subset-specific immunotherapy of B cell lymphomas VITALparticipant2.050.5008
2007-01-01Health-promotion through obesity prevention across Europe (hope): an integrated analysis to support European health policy HOPEparticipant1.061.2727
2006-11-01Chromatin Immuno-Linked Ligation [ChILL]: A novel generation of biotechnological tools for research and diagnosis CHILLparticipant1.800.4806
2006-10-01Polymorphic variations in apoptotic genes and cancer predisposition INTAS 2005-1000008-participant150.0005
2006-10-01Novel prevention and treatment possibilities for Otitis Media through the comprehensive identification of antigenic proteins OMVACparticipant2.321.0007
2006-06-01Analysis of the alternatively spliced isoforms of human intersectin 1 and 2: characterization of their expression patterns in normal and tumour tissues INTAS 2005-1000004-participant150.0004
2006-06-01Viral polymorphisms and clinical course of human Hepatitis C virus infection INTAS 2005-1000004-coordinator150.0005
2006-05-01The role of peroxiredoxin V in antioxidant defence, apoptosis and regulation of transcription INTAS 2005-1000004-coordinator147.3003
2006-01-01Presence: Research Encompassing Sensory Enhancement, Neuroscience, Cerebral-Computer Interfaces and Applications PRESENCCIAparticipant6.400.00014
2005-02-01Policy-oriented and harmonising research activities in the field of primary immunodeficiency diseases (PIDs) EURO-POLICY-PIDcoordinator1.879.8007
2004-10-06Macromolecule levitation test method LEVMACcoordinator665.4995
2004-09-01Not I micro-arrays for identification of new cancer-causing genes INTAS 2003-51-4983coordinator133.1257
2004-09-01Not I microarrays for identification of new cancer-causing genes. coordinator133.1257
2004-03-01EFFECTS OF THE EXPOSURE TO ELECTROMAGNETIC FIELDS: FROM SCIENCE TO PUBLIC HEALTH EMF-NETparticipant1.534.99439
2004-01-01Semantic Interoperability and Data Mining in Biomedicine SEMANTICMININGparticipant5.000.00023
2004-01-01The fusion of neuroscience and robotics for augmenting human capabilities NEUROBOTICSparticipant5.640.00017
2003-01-01DNA replication and biotechnological applications REPBIOTECHparticipant1.604.6616
2002-12-01Interplay among mitochondria and p53 family proteins during apoptosis induced by dna damage - a new strategy for cancer therapy IMPALEDcoordinator1.983.5477
2002-11-01Semliki forest virus based therapeutic systems SFVECTORSparticipant2.223.9577
2002-11-01Novel gene drug strategy based on hybridisation of functional entities to plasmids. EURO GENE DRUGcoordinator1.589.1434
2002-05-01Approximately Periodic Representation of Stimuli APERESTparticipant406.0003
2002-01-01Innovative therapeutics for the prototype autoimmune disease, myasthenia gravis IMMUNOTHERAPEUTICSparticipant1.822.9848
2001-11-01Suicide gene therapy in stem cell transplantation SGT IN SCTparticipant2.660.40013
2001-01-01Functional characterisation of orphan g protein-coupled receptors and their validation as drug targets ORPHAN RECEPTORSparticipant1.484.3685
2001-01-01Cellular production of human recombinant collagens, gelatins, laminins and growth factors and their use in vascular grafts and other applications MATRIX GRAFTSparticipant1.787.2816
2000-10-01Functional analysis of specific hnrnp proteins in balbiani-ring pre-mrnp particles FOMPROIX NATHALIEcoordinator142.4841
2000-02-01The c-ret receptor tyrosine kinase as a target for drug discovery C-RET DRUG DISCOVERYcoordinator1.244.0004
2000-02-01Antigen presentation by chaperon proteins and cd4+ t cell specific help for a new and efficient strategy of cancer vaccination. NEW CANCER VACCINESparticipant2.399.7298
2000-01-01X-ray structure analysis of pullulanases from hyperthermophilic archaea and bacteria JOYCE HELEN GERALDINcoordinator142.3841

Alias institution names:
  • KAROLINSKA INSTITUTE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum